JOSE IGNACIO RUIZ RODRIGUEZ

Allopathic & Osteopathic Physicians|Internal Medicine LAREDO, TX NPI 1669959649

General Payments — all program years on this page

$1,054.42

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 47
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $401.36 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $401.3621

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $75.284
2022 $149.244
2023 $428.5418
2024 $401.3621

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086158440 Bayer Healthcare Pharmaceuticals Inc. $19.70 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086171384 Bayer Healthcare Pharmaceuticals Inc. $20.34 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086188520 Bayer Healthcare Pharmaceuticals Inc. $18.54 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086256968 Bayer Healthcare Pharmaceuticals Inc. $18.54 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096717814 Novo Nordisk Inc $18.32 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096744006 Novo Nordisk Inc $18.50 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097166524 Novo Nordisk Inc $20.98 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104261811 AstraZeneca Pharmaceuticals LP $14.55 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105708844 AstraZeneca Pharmaceuticals LP $21.98 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105988193 ABBVIE INC. $17.81 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105988195 ABBVIE INC. $13.60 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105988197 ABBVIE INC. $26.84 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105988199 ABBVIE INC. $16.18 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114864702 Exact Sciences Corporation $23.02 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117370719 Amgen Inc. $17.23 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117370721 Amgen Inc. $17.34 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118104999 Boehringer Ingelheim Pharmaceuticals, Inc. $21.43 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135082450 Lilly USA, LLC $19.27 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135082452 Lilly USA, LLC $16.48 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135098284 Lilly USA, LLC $20.97 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135101979 Lilly USA, LLC $19.74 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.